Estimates of cancer incidence and mortality in Europe in 2008
- PMID: 20116997
- DOI: 10.1016/j.ejca.2009.12.014
Estimates of cancer incidence and mortality in Europe in 2008
Abstract
Up-to-date statistics on cancer occurrence and outcome are essential for the planning and evaluation of programmes for cancer control. Since the relevant information for 2008 is not generally available as yet, we used statistical models to estimate incidence and mortality data for 25 cancers in 40 European countries (grouped and individually) in 2008. The calculations are based on published data. If not collected, national rates were estimated from national mortality data and incidence and mortality data provided by local cancer registries of the same or neighbouring country. The estimated 2008 rates were applied to the corresponding country population estimates for 2008 to obtain an estimate of the numbers of cancer cases and deaths in Europe in 2008. There were an estimated 3.2 million new cases of cancer and 1.7 million deaths from cancer in 2008. The most common cancers were colorectal cancers (436,000 cases, 13.6% of the total), breast cancer (421,000, 13.1%), lung cancer (391,000, 12.2%) and prostate cancer (382,000, 11.9%). The most common causes of death from cancer were lung cancer (342,000 deaths, 19.9% of the total), colorectal cancer (212,000 deaths, 12.3%), breast cancer (129,000, 7.5%) and stomach cancer (117,000, 6.8%).
Copyright 2009 Elsevier Ltd. All rights reserved.
Similar articles
-
Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.Eur J Cancer. 2013 Apr;49(6):1374-403. doi: 10.1016/j.ejca.2012.12.027. Epub 2013 Feb 26. Eur J Cancer. 2013. PMID: 23485231
-
Estimates of cancer incidence and mortality in Europe in 1995.Eur J Cancer. 2002 Jan;38(1):99-166. doi: 10.1016/s0959-8049(01)00350-1. Eur J Cancer. 2002. PMID: 11750846
-
Estimates of the cancer incidence and mortality in Europe in 2006.Ann Oncol. 2007 Mar;18(3):581-92. doi: 10.1093/annonc/mdl498. Epub 2007 Feb 7. Ann Oncol. 2007. PMID: 17287242
-
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018.Eur J Cancer. 2018 Nov;103:356-387. doi: 10.1016/j.ejca.2018.07.005. Epub 2018 Aug 9. Eur J Cancer. 2018. PMID: 30100160 Review.
-
Epidemiology of cancer in the United States.Prim Care. 1992 Sep;19(3):419-41. Prim Care. 1992. PMID: 1410056 Review.
Cited by
-
Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapy.BMC Cancer. 2013 Feb 8;13:71. doi: 10.1186/1471-2407-13-71. BMC Cancer. 2013. PMID: 23394492 Free PMC article. Clinical Trial.
-
SYF2 is upregulated in human epithelial ovarian cancer and promotes cell proliferation.Tumour Biol. 2015 Jun;36(6):4633-42. doi: 10.1007/s13277-015-3111-1. Epub 2015 Jan 28. Tumour Biol. 2015. PMID: 25623116
-
National outcomes and uptake of laparoscopic gastrectomy for cancer in England.Surg Endosc. 2013 Sep;27(9):3348-58. doi: 10.1007/s00464-013-2916-5. Epub 2013 Apr 24. Surg Endosc. 2013. PMID: 23612763
-
CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemotherapy.Neoplasia. 2012 Aug;14(8):709-18. doi: 10.1593/neo.12324. Neoplasia. 2012. PMID: 22952424 Free PMC article.
-
Optimal management of renal cell carcinoma in the elderly: a review.Clin Interv Aging. 2013;8:433-42. doi: 10.2147/CIA.S30765. Epub 2013 Apr 19. Clin Interv Aging. 2013. PMID: 23626463 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical